| Preface | p. vii |
| Psychiatric History and Mental Status Examination | p. 1 |
| Physical Illness and Psychiatric Disorder | p. 10 |
| Laboratory Tests in Psychiatry | p. 16 |
| Signs and Symptoms in Psychiatry | p. 21 |
| Classification in Psychiatry | p. 33 |
| Psychiatric Rating Scales | p. 40 |
| Delirium, Dementia, Amnestic, and Other Cognitive Disorders and Mental Disorders Due to a General Medical Condition | p. 46 |
| Overview | p. 46 |
| Delirium | p. 48 |
| Dementia | p. 52 |
| Amnestic Disorders | p. 60 |
| Mental Disorders Due to a General Medical Condition | p. 65 |
| Neuropsychiatric Aspects of HIV Infection and AIDS | p. 80 |
| Substance-Related Disorders | p. 85 |
| Introduction and Overview | p. 85 |
| Alcohol-Related Disorders | p. 90 |
| Amphetamine (or Amphetamine-like)-Related Disorders | p. 105 |
| Caffeine-Related Disorders | p. 110 |
| Cannabis-Related Disorders | p. 114 |
| Cocaine-Related Disorders | p. 117 |
| Hallucinogen-Related Disorders | p. 123 |
| Inhalant-Related Disorders | p. 129 |
| Nicotine-Related Disorders | p. 132 |
| Opioid-Related Disorders | p. 136 |
| Phencyclidine (or Phencyclidine-like)-Related Disorders | p. 142 |
| Sedative-, Hypnotic-, or Anxiolytic-Related Disorders | p. 145 |
| Anabolic-Androgenic Steroid Abuse | p. 150 |
| Other Substance-Related Disorders | p. 152 |
| Schizophrenia | p. 156 |
| Other Psychotic Disorders | p. 178 |
| Schizophreniform Disorder | p. 178 |
| Schizoaffective Disorder | p. 180 |
| Delusional Disorder and Shared Psychotic Disorder | p. 182 |
| Brief Psychotic Disorder, Psychotic Disorder Not Otherwise Specified, and Secondary Psychotic Disorders | p. 190 |
| Culture-Bound Syndromes | p. 195 |
| Mood Disorders | p. 200 |
| Depression and Bipolar Disorder | p. 200 |
| Dysthymia and Cyclothymia | p. 225 |
| Other Mood Disorders | p. 230 |
| Anxiety Disorders | p. 236 |
| Overview | p. 236 |
| Panic Disorder and Agoraphobia | p. 239 |
| Specific Phobia and Social Phobia | p. 247 |
| Obsessive-Compulsive Disorder | p. 253 |
| Posttraumatic Stress Disorder and Acute Stress Disorder | p. 258 |
| Generalized Anxiety Disorder | p. 263 |
| Other Anxiety Disorders | p. 267 |
| Somatoform Disorders | p. 273 |
| Factitious Disorders | p. 287 |
| Dissociative Disorders | p. 293 |
| Human Sexuality | p. 303 |
| Normal Sexuality | p. 303 |
| Abnormal Sexuality and Sexual Dysfunctions | p. 306 |
| Paraphilias and Sexual Disorder Not Otherwise Specified | p. 318 |
| Gender Identity Disorders | p. 326 |
| Eating Disorders | p. 333 |
| Anorexia Nervosa | p. 333 |
| Bulimia Nervosa and Eating Disorder Not Otherwise Specified | p. 338 |
| Obesity | p. 341 |
| Normal Sleep and Sleep Disorders | p. 346 |
| Normal Sleep | p. 346 |
| Sleep Disorders | p. 348 |
| Impulse-Control Disorders Not Elsewhere Classified | p. 360 |
| Adjustment Disorders | p. 371 |
| Personality Disorders | p. 375 |
| Psychosomatic Medicine | p. 393 |
| Consultation-Liaison Psychiatry | p. 400 |
| Psychiatry and Reproductive Medicine | p. 403 |
| Relational Problems | p. 410 |
| Problems Related to Abuse or Neglect | p. 414 |
| Additional Conditions That May Be a Focus of Clinical Attention | p. 421 |
| Emergency Psychiatric Medicine | p. 428 |
| Suicide | p. 428 |
| Other Psychiatric Emergencies | p. 434 |
| Psychotherapies | p. 445 |
| Psychoanalysis and Psychoanalytic Psychotherapy | p. 445 |
| Brief Psychodynamic Psychotherapy | p. 449 |
| Group Psychotherapy, Combined Individual and Group Psychotherapy, and Psychodrama | p. 451 |
| Family Therapy and Couples Therapy | p. 454 |
| Dialectical Behavior Therapy | p. 456 |
| Genetic Counseling | p. 457 |
| Biofeedback | p. 457 |
| Behavior Therapy | p. 458 |
| Cognitive Therapy | p. 461 |
| Hypnosis | p. 463 |
| Interpersonal Therapy | p. 464 |
| Psychiatric Rehabilitation | p. 466 |
| Biological Therapies | p. 468 |
| General Principles of Psychopharmacology | p. 468 |
| Medication-Induced Movement Disorders | p. 472 |
| [alpha subscript 2]-Adrenergic Receptor Agonists: Clonidine and Guanfacine | p. 475 |
| [beta]-Adrenergic Receptor Antagonists | p. 477 |
| Anticholinergics and Amantadine | p. 479 |
| Anticonvulsants: Gabapentin, Pregabalin, Tiagabine, Levetiracetam, Topiramate, and Zonisamide | p. 481 |
| Antihistamines | p. 483 |
| Barbiturates and Similarly Acting Drugs | p. 485 |
| Benzodiazepines and Drugs Acting on Benzodiazepine Receptors | p. 488 |
| Bupropion | p. 492 |
| Buspirone | p. 494 |
| Calcium Channel Inhibitors | p. 495 |
| Carbamazepine and Oxcarbazepine | p. 496 |
| Cholinesterase Inhibitors and Memantine | p. 499 |
| Dantrolene | p. 502 |
| Disulfiram and Acamprosate | p. 502 |
| Dopamine Receptor Agonists and Precursors: Apomorphine, Bromocriptine, Levodopa, Pergolide, Pramipexole, and Ropinirole | p. 504 |
| Dopamine Receptor Antagonists: Typical Antipsychotics | p. 506 |
| Lamotrigine | p. 513 |
| Lithium | p. 514 |
| Melatonin Agonists: Ramelteon and Melatonin | p. 519 |
| Mirtazapine | p. 520 |
| Monoamine Oxidase Inhibitors | p. 521 |
| Nefazodone | p. 524 |
| Opioid Receptor Agonists: Methadone, Buprenorphine, and Levomethadyl | p. 526 |
| Opioid Receptor Antagonists: Naltrexone, Nalmefene, and Naloxone | p. 528 |
| Phosphodiesterase-5 Inhibitors | p. 531 |
| Selective Serotonin-Norepinephrine Reuptake Inhibitors | p. 533 |
| Selective Serotonin Reuptake Inhibitors | p. 535 |
| Serotonin-Dopamine Antagonists: Atypical Antipsychotics | p. 542 |
| Sympathomimetics and Related Drugs | p. 548 |
| Thyroid Hormones | p. 552 |
| Trazodone | p. 554 |
| Tricyclics and Tetracyclics | p. 555 |
| Valproate | p. 559 |
| Yohimbine | p. 561 |
| Electroconvulsive Therapy | p. 562 |
| Other Brain Stimulation Methods | p. 566 |
| Child Psychiatry: Assessment, Examination, and Psychological Testing | p. 568 |
| Mental Retardation | p. 575 |
| Learning Disorders | p. 585 |
| Motor Skills Disorder: Developmental Coordination Disorder | p. 592 |
| Communication Disorders | p. 595 |
| Pervasive Developmental Disorders | p. 605 |
| Attention-Deficit Disorders | p. 616 |
| Disruptive Behavior Disorders: Oppositional Defiant Disorder and Conduct Disorder | p. 623 |
| Feeding and Eating Disorders of Infancy or Early Childhood | p. 629 |
| Tic Disorders | p. 634 |
| Elimination Disorders | p. 639 |
| Other Disorders of Infancy, Childhood, and Adolescence | p. 644 |
| Reactive Attachment Disorder of Infancy or Early Childhood | p. 644 |
| Stereotypic Movement Disorder and Disorder of Infancy, Childhood, or Adolescence Not Otherwise Specified | p. 646 |
| Mood Disorders and Suicide in Children and Adolescents | p. 650 |
| Depressive Disorders and Suicide in Children and Adolescents | p. 650 |
| Early-Onset Bipolar Disorders | p. 656 |
| Anxiety Disorders of Infancy, Childhood, and Adolescence | p. 659 |
| Obsessive-Compulsive Disorder of Infancy, Childhood, and Adolescence | p. 659 |
| Separation Anxiety Disorder, Generalized Anxiety Disorder, and Social Phobia | p. 662 |
| Selective Mutism | p. 667 |
| Early-Onset Schizophrenia | p. 669 |
| Child Psychiatry: Additional Conditions That May Be a Focus of Clinical Attention | p. 673 |
| Psychiatric Treatment of Children and Adolescents | p. 679 |
| Individual Psychotherapy | p. 679 |
| Group Psychotherapy | p. 682 |
| Residential, Day, and Hospital Treatment | p. 684 |
| Biological Therapies | p. 686 |
| Psychiatric Treatment of Adolescents | p. 690 |
| Geriatric Psychiatry | p. 694 |
| End of Life Care | p. 698 |
| Palliative Care | p. 698 |
| Euthanasia and Physician-Assisted Suicide | p. 700 |
| Clinical-Legal Issues in Psychiatry | p. 703 |
| Ethics in Psychiatry | p. 709 |
| Index | p. 712 |
| Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.